Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
IMPACT Therapeutics
company
About
IMPACT Therapeutics is a China based Company.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $50M
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jun 1, 2009
- Number Of Employee
- 1 - 10
- Operating Status
- Active
IMPACT Therapeutics is dedicated to the development of similar drugs to treat cancer have independent intellectual property rights and other diseases of the best (best-in-class) of new drugs and its commercialization. The company's senior management team of experienced and professional background complementary and have accumulated more than four decades of experience in drug development and management. General Manager and Chief Scientific Officer Field are an expert in pharmacology and biology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
$90M
IMPACT Therapeutics has raised a total of
$90M
in funding over 2 rounds. Their latest funding was raised on
Mar 14, 2022 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 14, 2022 | Series D | — | 4 | — | — | Detail |
| Dec 1, 2020 | Series C | $50M | 4 | — | — | Detail |
| Aug 3, 2018 | Series C | $30M | 1 | — | — | Detail |
| Feb 22, 2016 | Series B | $10M | 2 | — | — | Detail |
| Jul 7, 2014 | Series A | — | 1 |
Lilly Asia Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
6
IMPACT Therapeutics is funded by 6 investors.
China Summit Capital
and Bestride
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
|
|
— | Series D |
CCBT Private Equity
|
— | Series D |
|
Lilly Asia Ventures
|
— | Series D |
|
|
— | Series C |
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
